Sistema de Información Esencial en Terapéutica y Salud

@SIETES7

Última actualización: 16/10/2019
SIETES contiene 92824 citas

 
 
 1 a 20 de 157 siguiente >>
Presentar resultados
Seleccionar todas
1.Enlace a cita originalTiene citas relacionadas Cita con resumen
Newman CB, Preiss D, Tobert JA, Jacobson TA, Page II RL, Goldstein LB, Chin C, Tannock LR, Miller M, Raghuveer G, Duell PB, Brinton EA, Pollak A, Braun LT, Welty FK. Statin safety and associated adverse events: a scientific statement from the American Heart Association. Arteriosclerosis, Thrombosis, and Vascular Biology 2019;39:enero. [Ref.ID 103011]
2. Cita con resumen
Maier L, Pruteanu M, Kuhn M, Zeller G, Telzerow A, Anderson EE, Brochado AR, Fernandez KC, Dose H, Mori H, Patil KR, Bork P, Typas A. Extensive impact of non-antibiotic drugs on human gut bacteria. Nature 2018;555:29 de marzo. [Ref.ID 102577]
3. Cita con resumen
Varga S, Alcusky M, Keith SW, Hegarty SE, Del Canale S, Lombardi M, Maio V. Hospitalization rates during potentially inappropriate medication use in a large population-based cohort of older adults. Br J Clin Pharmacol 2017;83:2572-80. [Ref.ID 102117]
4. Cita con resumen
Anónimo. Excès de poils d'origine médicamenteuse. Prescrire 2017;37:26. [Ref.ID 101367]
5.Enlace a cita original Cita con resumen
Martinez C, Suissa S, McGill J, Rietbrock S, Katholing A, Freedman B, Cohen AT, Handelsman DJ. Testosterone treatment and risk of venous thromboembolism: population based case-control study. BMJ 2016;355:i5968. [Ref.ID 101016]
7. Cita con resumen
Cunningham GR, Stephens-Shields AJ, Rosen RC, Wang C, Bhasin S, Matsumoto AM, Parsons JK, Gill TM, Molitch ME, Farrar JT, Cella D, Barrett-Connor E, Cauley JA, Cifelli D, Crandall JP, Ensrud KE, Gallagher L, Zeldow B, Lewis CE, Pahor M, Swerdloff RS, Hou X, Anton S, Basaria S, Diem SJ, Tabatabaie V, Ellenberg SS, Snyder PJ. Testosterone treatment and sexual function in older men with low testosterone levels. J Clin Endocrinol Metab 2016;101:3096-104. [Ref.ID 100597]
8. Cita con resumen
Snyder PJ, Bhasin S, Cunningham GR, Matsumoto AM, Stephens-Shields AJ, Cauley JA, Gill TM, Barrett-Connor E, Swerdloff RS, Wang C, Ensrud KE, Lewis CE, Farrar JT, Cella D, Rosen RC, Pahor M, Crandall JP, Molitch ME, Cifelli D, Dougar D, Fluharty L, Resnick SM, Storer TW, Anton S, Basaria S, Diem SJ, Hou X, Mohler ER, Parsons JK, Wenger NK, Zeldow B, Landis JR, Ellenberg SS, for the Testosterone Trials Investigators. Effects of testosterone treatment in older men. N Engl J Med 2016;374:611-24. [Ref.ID 100026]
9. Cita con resumen
Hampton T. Acetaminophen during pregnancy may affect offspring’s testes. JAMA 2015;314:16. [Ref.ID 99334]
10. Cita con resumen
Anónimo. FDA to require warning on labels of testosterone products. DIA Daily 2015:4 de marzo. [Ref.ID 98821]
11. Cita con resumen
Anónimo. FDA advisory panel recommends curbs on testosterone medications. DIA Daily 2014:18 de septiembre. [Ref.ID 97925]
12. Cita con resumen
Lu-Yao GL, Albertsen PC, Moore DF, Shih W, Lin Y, DiPaola RS, Yao S-L. Fifteen-year survival outcomes following primary androgen-deprivation therapy for localized prostate cancer. JAMA Intern Med 2014;174:1460-7. [Ref.ID 97899]
13.Enlace a cita original Cita con resumen
Anónimo. FDA adding general warning to testosterone products about potential for venous blood clots. U.S. Food and Drug Administration 2014:19 de junio. [Ref.ID 97716]
14. Cita con resumen
Anónimo. Testosterone and cardiovascular risk. Med Lett Drugs Ther 2014;56:17. [Ref.ID 97419]
15. Cita con resumen
Anónimo. US drug regulator investigates safety of testosterone. BMJ 2014;348:2. [Ref.ID 97249]
16.Tiene citas relacionadas Cita con resumen
Anónimo. Comportements violents envers autrui sous l'effet de médicaments. Prescrire 2014;34:110-3. [Ref.ID 97126]
17.Enlace a cita original Cita con resumen
Anónimo. Testosterone Products: Drug Safety Communication - FDA Investigating Risk of Cardiovascular Events. U.S. Food and Drug Administration 2014:1. [Ref.ID 97103]
18. Cita con resumen
Finkle WD, Greenland S, Ridgeway GK, Adams JL, Frasco MA, Cook MB, Fraumeni Jr JF, Hoover RN. Increased risk of non-fatal myocardial infarction following testosterone therapy prescription in men. PLoS One 2014;9:e85805. [Ref.ID 97080]
19. Cita con resumen
Vigen R, O'Donnell CI, Barón AE, Grunwald GK, Maddox TM, Bradley SM, Barqawi A, Woning G, Wierman ME, Plomondon ME, Rumsfeld JS, Ho PM. Association of testosterone therapy with mortality, miocardial infarction, and stroke in men with low testosterone levels. JAMA 2013;310:1829-36. [Ref.ID 96689]
20. Cita con resumen
Spitzer M, Basaria S, Travison TG, Davda MN, Paley A, Cohen B, Mazer MA, Knapp PE, Hanka S, Lakshman KM, Ulloor J, Zhang A, Orwoll K, Eder R, Collins L, Mohammed N, Rosen RC, DeRogatis L, Shasin S. Effect of testosterone replacement on response to sildenafil citrate in men with erectible dysfunction: a parallel, randomized trial. Ann Intern Med 2012;157:681-91. [Ref.ID 94088]
Seleccionar todas
 
 1 a 20 de 157 siguiente >>